Skip to main content
. Author manuscript; available in PMC: 2014 Mar 9.
Published in final edited form as: Cytokine. 2013 Apr 17;62(3):369–381. doi: 10.1016/j.cyto.2013.03.027

Fig. 1.

Fig. 1

Human postmortem eye with AGE immunoreactivity. Intensity of AGE immunoreactivity in the outer retina of the AMD eye with drusen (>70 yrs of age) compared to a young, normal eye without drusen (<55 yrs of age). Intense immunoreactivity (purple) is seen in Bruch’s membrane (BM) and choroid (Ch) in the older donor eye with drusen (A). In the younger eye (<55 yrs), less immunoreactivity is seen in choroid and BM (B). Replacement of the primary antibody with a non-specific IgG serum served as control and demonstrated non-specific background immunoreactivity levels (C). Scale bar is (C) represents magnification for A–C.